The Genomics Hub
Your end to end service for assay validation, quality control, variant interpretation and reporting.
Flexible and detailed filtering strategies integrating the best public databases to annotate one or several VCF files streamlined directly from our secondary analysis workflow.
Make diagnostic analysis based on high quality data with automated ACMG classification, ASCO/AMP tiering in a simple user interface.
Report primary & secondary findings using our template reports that can be tailored to the laboratory needs (customer requirements).
Stay compliant with regulations by quick validation and verification tools for your pipeline, with easy to read graphical representations of sensitivity, precision and level of detection.
Sample Quality Control
Bring reproducible & robust data over time by automated tools to flag failing and warning samples based on your thresholds.
Access over 60 quality metrics and track data over time for quality trends.
Why the Genomics Hub?
An end to end sequencing service saves you time and money.
Genomics Hub streamlines an efficient workflow at your lab by automatically connecting variant interpretation with quality control, assay validation and custom clinical reporting according to your needs.
Hence, less time spent battling laborious excel-sheets, so your team can focus on diagnostic analysis & therapeutic decisions…
Are we missing something?
Genomics Hub is a true SaaS product, which means constant iteration cycles. We would love to hear what improves & personalize our solution for you.
Who we work with
Our clients and partners share our vision of a future in which patients receive better care through genomic data analysis.
At the forefront of next generation sequencing science
EMQN, UK NEQAS for Molecular Genetics, and Euformatics gear up for EQA 2016 Pilot
| Genomics Hub Blog
The team from UK NEQAS for Molecular Genetics and the European Molecular Genetics Quality Network EM…
Euformatics selected for GEMMA H2020 project to provide genomics analysis and quality control for Autism Spectrum Disorders
| GEMMA H2020
ESPOO, Finland, October, 2018. – Finnish bioinformatics company, Euformatics has received 0.7 mi…
Euformatics and BC Platforms Mark Major Partnership Milestone with Helsinki University Hospital
Introduction Euformatics has signed an agreement with BC Platforms to deliver one of Europe’s larg…